Submitted by dcc on Mon, 2024-01-22 12:53 Study Title: A Phase II Study of Androgen Receptor (AR) Inhibition by Darolutamide in Combination with Leuprolide Acetate and Exemestane in Recurrent Adult-Type Ovarian Granulosa Cell TumorCIRB: Adult CIRB - Late Phase EmphasisLead Group: NRGStatus: ActiveReview Status: Available to Open
